AZT-01 (Therapeutic Nucleases)
Inflammatory & Fibrotic Diseases (e.g., Lupus, RA)
Pre-clinicalLead Optimization
Key Facts
Indication
Inflammatory & Fibrotic Diseases (e.g., Lupus, RA)
Phase
Pre-clinical
Status
Lead Optimization
Company
About ArcticZymes Technologies ASA
ArcticZymes Technologies ASA is a public biotech company that develops and commercializes unique enzymes derived from organisms adapted to the extreme cold of the Arctic. Its core technology platform focuses on cold-adapted enzymes, including nucleases, polymerases, and phosphatases, which offer advantages in molecular biology, diagnostics, and next-generation sequencing workflows. The company operates both a product business for research use and a therapeutic discovery pipeline, with strategic partnerships to expand its market reach. Its mission is to translate the unique properties of Arctic biomolecules into innovative tools and potential medicines.
View full company profile